Mutations in the nijmegen breakage syndrome gene in medulloblastomas

Clinical Cancer Research

Volumn 14, Issue 13, 2008, Pages 4053-4058

  Huang, Jian ^a   Grotzer, Michael A ^b   Watanabe, Takuya ^a   Hewer, Ekkehard ^c   Pietsch, Torsten ^d   Rutkowski, Stefan ^e   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; NIBRIN; PROTEIN MDM2; PROTEIN P53; CELL CYCLE PROTEIN; NBN PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDULLOBLASTOMA; METHYLATION; MISSENSE MUTATION; NIJMEGEN BREAKAGE SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; ALTERNATIVE RNA SPLICING; GENETICS; INFANT; MUTATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ALTERNATIVE SPLICING; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; MUTATION; NIJMEGEN BREAKAGE SYNDROME; NUCLEAR PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 48249134779     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0098     Document Type: Article

References (56)

1. Louis DN, Ohgaki H. Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. Lyon: IARC; 2007.
2. Lantos PL, Louis DN, Rosenblum MK, Kleihues P. Tumours of the nervous system. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology, 7th ed. London: Arnold; 2002. pp. 767-1052.
3. Kumar R, Tekkok IH, Jones RA. Intracranial tumours in the first 18 months of life. Childs Nerv Syst 1990;6: 371-4.
4. Eberhart CG, Cavenee WK, Pietsch T. Naevoid basal cell carcinoma syndrome. In: Louis DN, Ohgaki H, Wiestler OD, CaveneeWK, editors.WHO classification of tumours of the central nervous system. Lyon: IARC; 2007. pp. 232-3.
5. CaveneeWK, Burger PC, Leung SY, Van Meir EG. Turcot syndrome. In: Louis DN, Ohgaki H. Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. Lyon: IARC; 2007. pp. 229-31.
6. Paulli M, Viglio A, Boveri E, et al. Nijmegen breakage syndrome-associated T-cell-rich B-cell lymphoma: case report. Pediatr Dev Pathol 2000;3:264-70.
7. Hama S, Matsuura S, Tauchi H, et al. Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients. Anticancer Res 2000;20:1897-900.
8. Kruger L, Demuth I, Neitzel H, et al. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis 2007;28:107-11.
9. Varan R, Vissinga C, Platter M, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998;93:467-76.
10. Varon R, Seemanova E, Chrzanowska K, et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 2000;8:900-2.
11. Distel L, Neubauer S, Varon R, Holter W, Grabenbauer G. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome Med Pediatr Oncol 2003;41:44-8.
12. Bakhshi S, Cerosaletti KM, Concannon P, et al. Medulloblastoma with adverse reaction to radiation therapy in Nijmegen breakage syndrome. J Pediatr Hematol Oncol 2003;25:248-51.
13. Kang J, Ferguson D, Song H, et al. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol Cell Biol 2005;25:661-70.
14. Carney JP, Maser RS, Olivares H, et al. The hMrelV hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998;93: 477-86.
15. Kitagawa R, Kastan MB. The ATM-dependent DNA damage signaling pathway. Cold Spring Harb Symp Quant Biol 2005;70:99-109.
16. Difilippantonio S, Celeste A, Kruhlak MJ, et al. Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis. J Exp Med 2007;204: 1003-11.
17. Alt JR. Bouska A, Fernandez MR, Cemy RL, Xiao H, Eischen CM. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair. J Biol Chem 2005;280:18771-81.
18. Badiali M, lolascon A, Loda M, et al. p53 gene mutations in medulloblastoma. lmmunohistochemistry, gel shift analysis, and sequencing. Diagn Mol Pathol 1993;2:23-8.
19. Watanabe K, Peraud A, Gratas CWakai S, Kleihues P, Ohgaki H. p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol 1998;95: 559-64.
20. Arf deletion and methylation in genetic pathways to glioblastomas. Brain Pathol 2001;11:159-68.
21. Tohma Y, Gratas C, Biemat W, et al. PTEN (MMACI) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 1998;57:684-9.
22. Kuschel B, Auranen A, McBride S, et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 2002;11: 1399-1407.
23. Cerosaletti KM, Morrison VA, Sabath DE, Willerford DM, Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer 2002;35:282-6.
24. Ziolkowska I, Mosor M, Wierzbicka M, Rydzanicz M, Pernak-Schwarz M, Nowak J. Increased risk of larynx cancer in heterozygous carriers of the 1171V mutation of the NBS1 gene. Cancer Sci 2007;98:1701-5.
25. Hebbring SJ, Fredriksson H, White KA, et al. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:935-8.
26. Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD. Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 1988;30: 91-101.
27. Griffin CA, Hawkins AL, Packer RJ, Rorke LB, Emanuel BS. Chromosome abnormalities in pediatric brain tumors. Cancer Res 1988;48:175-80.
28. James CD, He J, Carlbom E, et al. Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chromosomes Cancer1990;2:94-102.
29. Albrecht S, von Deimling A, Pietsch T, et al. Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas. Neuropathol Appl Neurobiol 1994;20:74-81.
30. Schutz BR, Scheurlen W, Krauss J, et al. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1996;16:196-203.
31. Reardon DA, Michalkiewicz E, Boyett JM, et al. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 1997;57:4042-7.
32. Avet-Loiseau H, Venuat AM, Terrier-Lacombe MJ, Lellouch-Tubiana A, Zerah M, Vassal G. Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children. Br J Cancer 1999;79: 1843-7.
33. Raffel C, Jenkins RB, Frederick L, et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997;57:842-5.
34. Wolter M, Reifenberger J, Sommer C, RuzickaT, Reifenberger G. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1997;57:2581-5.
35. Zurawel RH, Allen C, Chiappa S, et al. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 2000;27:44-51.
36. Giangaspero F, Eberhart CG, Haapasalo H, Pietsch T, Wiestler OD, Ellison DW. Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. Lyon: IARC; 2007. pp. 132-40.
37. Wetmore C, Eberhart DE, CurranT Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res 2001;61:513-6.
38. Marino S, Vooijs M, van Der GH, Jonkers J. Bems A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 2000;14:994-1004.
39. Tong WM, Ohgaki H, Huang H. Granier C. Kleihues P. Wang ZQ. Null mutation of DNA strand break-binding molecule poly (ADP-ribose) polymerase causes medulloblastomas in p53-/-mice. Am J Pathol 2003; 162:343-52.
40. Lee Y, McKinnon PJ. DNA ligase IV suppresses medulloblastoma formation. Cancer Res 2002;62: 6395-9.
41. Zurawel RH, Chiappa SA, Allen C, Raffel C Sporadic medulloblastomas contain oncogenic b-catenin mutations. Cancer Res1998;58:896-9
42. Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of b-catenin in medulloblastomas J Neuropathol Exp Neurol 2000;59:333-7.
43. Huang H, Mahler-Araujo BM, Sankila A. et al APC mutations in sporadic medulloblastomas Am J Pathol 2000;156;433-7
44. Dahmen RP, Koch A, Denkhaus D, et al, Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001;61:7039-43.
45. Baeza N, Masuoka J, Kleihues P. Ohgaki H. AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 2003;22:632-6.
46. Lee JH, Xu B, Lee CH, et al. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage Mol Cancer Res 2003;1:674-81
47. Zhao S, Renthal W, Lee EY Functional analysis of FHA and BRCT domains of NBS1 in chromatin association and DNA damage responses Nucleic Acids Res 2002;30:4815-22.
48. Williams RS, Williams JS, Tainer JA. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. Biochem Cell Biol 2007;85 509-20.
49. Tauchi H, Kobayashi J, Morishima K, et al The forkhead-associated domain of NBS1 is essential for nuclear foci formation after irradiation but not essential for hRAD50 hMRE11 NBS1 complex DNA repair activity. J Biol Chem 2001;276:12-5
50. Lu J, Wei Q, Bondy ML, et al. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women < or = 55 years. Carcinogenesis 2006;27 2209-16.
51. Di Masi A, Antoccia A, Spadoni E, Varon-Mateeva R, Maraschio P, Tanzarella C. Screening of Nijmegen breakage syndrome 1 mutations in four unrelated families by polymerase chain reaction using sequence-specific primers. Genet Test 2006;10:24-30
52. Ebi H, Matsuo K, Sugito N, et al. Novel NBS1 heterozygous germ line mutation causing MRE11 - binding domain loss predisposes to common types of cancer Cancer Res 2007;67:11158-65
53. Bogdanova N, Feshchenko S. Schurmann P. et al Nijmegen breakage syndrome mutations and risk of breast cancer Int J Cancer 2008;122:802-6
54. Heikkinen K, Rapakko K, Karppinen SM, et al RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability Carcinogenesis 2006;27:1593-9.
55. Varon R, Reis A, Henze G, von Einsiedel HG, Sperling K, Seeger K. Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res 2001:61 3570-2.
56. Shimada H, Shimizu K, Mimaki S, et al. First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (1171V) associated with genomic instability. Hum Genet 2004;115:372-6.